1.
Impact of Xerosis in Patients With Cancer Receiving Epidermal Growth Factor Receptor or Mitogen-Activated Protein Kinase Inhibitors: ATIXI, A Non-Interventional, Prospective, Pilot Study. Dermatol Pract Concept [Internet]. 2024 Oct. 30 [cited 2024 Dec. 10];14(4):e2024259. Available from: https://dpcj.org/index.php/dpc/article/view/4390